“I was running out of options. Cancer Commons helped me find the clinical trial that saved my life.”

Jill, 38 | Stage III breast cancer

Our network of the world’s top cancer experts reviewed Jill’s case, helping her better understand her diagnosis and treatment options. We can help you, too.

Ask Cancer Commons

Don’t have a question?
Sign up for updates.

Save Lives Today,
Transform Cancer Care Tomorrow

Cancer Commons is a nonprofit network of patients, physicians, scientists, and volunteers.
We provide you with personalized information, continuously refined by patient experiences.

Learn more about us

What Patients are Saying…

Laura G.

Patient caregiver

“Thank you so much for all of this valuable information. It will shape my next questions to my mom’s medical team. Unfortunately, there is less of a medical team and more silos of treatment recommendations. This leaves me to try to navigate the system based on my own research and thankfully seeking good advice out there from entities like Cancer Commons, one of the few organizations that is actively promoting patients having a strong, educated voice in their treatment.”

Become a Volunteer

Cancer Commons is supported by volunteers interacting with patients,
researching treatment options, curating information, writing code, or raising funds.
We need you!

I want to help

Need to Know Blog

From patient stories to the latest trials, stay on the top of the most important cancer news.
Read all the latest news for Breast Cancer, Lung Cancer, Melanoma,
Neuroendocrine Tumors, and Prostate Cancer

Super Patient: Janet Freeman-Daily Joins a Clinical Trial—and Beats the Odds on Lung Cancer

Robin Meadows | Nov 2 2015

In March 2011, Janet Freeman-Daily was about to take a long family trip to China. She’d been coughing for a while, so she asked her doctor for an antibiotic as a precaution before leaving…

More Super Patients:
Laura Gheorghiu Seeks Better Care for Her Mom—and for Cancer Patients Across Canada

Finally: An Active Prostate Cancer Drug That Doesn’t Target Androgen

Emma Shtivelman | Nov 10 2015

This month’s big news is a welcome change: metastatic castration-resistant prostate cancers (mCRPCs) that harbor mutations in BRCA2 or one of a few other genes have a remarkable response to olaparib…

Read more:
Breast Cancer | Lung Cancer
Melanoma | NET | Prostate Cancer